iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
166.86
+4.51 (2.78%)
Aug 13, 2025, 4:00 PM - Market closed
iRhythm Technologies Market Cap
iRhythm Technologies has a market cap or net worth of $5.36 billion as of August 13, 2025. Its market cap has increased by 94.59% in one year.
Market Cap
5.36B
Enterprise Value
5.55B
1-Year Change
94.59%
Ranking
Category
Stock Price
$166.86
Market Cap Chart
Since October 20, 2016, iRhythm Technologies's market cap has increased from $525.70M to $5.36B, an increase of 919.75%. That is a compound annual growth rate of 30.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 5.36B | 89.96% |
| Dec 31, 2024 | 2.82B | -13.98% |
| Dec 29, 2023 | 3.28B | 16.32% |
| Dec 30, 2022 | 2.82B | -18.56% |
| Dec 31, 2021 | 3.46B | -49.43% |
| Dec 31, 2020 | 6.85B | 277.77% |
| Dec 31, 2019 | 1.81B | 7.90% |
| Dec 31, 2018 | 1.68B | 30.44% |
| Dec 29, 2017 | 1.29B | 94.05% |
| Dec 30, 2016 | 663.80M | 26.27% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |